logo

EN
KO

PLATFORM & PIPELINE

Based on good will, we continuously strive to innovate science
and technology to improve the quality of life of patients and their families.

PLATFORM & PIPELINE

PIPELINE

INHOUSE Program
TA Target Indication Pipeline Proof of
Mechanism		 Hit-to-Lead Lead Opt. Pre-clinical Clinical
Neurology Aβ Alzheimer’s disease ILM01
Tau Tauopathies ILM02
Immunology Myelin Debris Multiple Sclerosis ILM21
TNFα IBD ILM22
Early R&D Collaboration (based on GAIA Platform)
Partner Target Collaboration Model Design Production In vitro In vivo
Undisclosed Catalyze360-ExploR&D
US Biotech Undisclosed GAIA + Antibody
US Research
Institute		 Multiple Targets GAIA + De-novo binder